Skip to main content

Table 4 The association between BPE and tumor characteristics among women with breast cancer in the IMAGINE study

From: Association of breast cancer with MRI background parenchymal enhancement: the IMAGINE case-control study

Premenopausal cases

Tumor characteristic

Minimal/mild BPE

Moderate/marked BPEa

ORb

95% CI

Hormone receptor statusc

 Negative

48 (15%)

33 (16%)

Reference

 

 Positive

277 (85%)

178 (84%)

1.00

0.59–1.68

HER2

 Negative

277 (85%)

164 (78%)

Reference

 

 Positive

48 (15%)

47 (22%)

1.72

1.07–2.76

Histology

 Ductal

293 (90%)

194 (92%)

Reference

 

 Lobular/mixed/other

32 (10%)

17 (8%)

0.99

0.52–1.91

Stage

 Localized

220 (68%)

147 (70%)

Reference

 

 Regional

101 (31%)

60 (28%)

0.86

0.57–1.29

 Distant

4 (1%)

4 (2%)

1.45

0.34–6.21

Postmenopausal cases

Tumor characteristic

Minimal BPE

Mild/moderate/marked BPE

ORb

95% CI

Hormone receptor status

 Negative

26 (27%)

30 (17%)

Reference

 

 Positivec

71 (73%)

145 (83%)

2.55

1.22–5.34

Human epidermal growth factor 2

 Negative

83 (86%)

152 (87%)

Reference

 

 Positive

14 (14%)

23 (13%)

0.89

0.37–2.13

Histology

 Ductal

80 (82%)

151 (86%)

Reference

 

 Lobular/mixed/other

17 (18%)

24 (14%)

0.65

0.30–1.43

Stage

 Localized

76 (78%)

132 (75%)

Reference

 

 Regional

19 (20%)

41 (23%)

0.75

0.36–1.53

 Distant

2 (2%)

2 (1%)

0.36

0.04–3.17

  1. Abbreviations: OR odds ratio, CI confidence interval, ER estrogen receptor, PR progesterone receptor, HER2 human epidermal growth factor 2
  2. aEstimated for a single unaffected breast using BI-RADS (Breast Imaging - Reporting and Data System) guidelines by a single research radiologist blinded to case-control status, clinical characteristics, and medical history
  3. bMultivariable-adjusted odds ratio for BPE category estimated in logistic regression with additional adjustment for (heterogeneous/dense vs fatty/scattered); BMI (< 25, ≥25 and < 30, ≥ 30 kg/m2); and conditioned on matching criteria: race/ethnicity (non-Hispanic White vs other), recruitment site, and age at MRI (5-year categories)
  4. cConsidered positive if positive for estrogen or progesterone receptors